Maxine S. Jochelson

Contrast-enhanced Mammography for Breast Cancer Screening in Women at Increased Risk: Comparison of Prevalence and Incidence Screens

Cheng‐Han Lee, Tali Amir, Varadan Sevilimedu, Sarah Eskreis‐Winkler et autres

The ability of contrast-enhanced mammography to help detect cancer during prevalence screening in women at increased risk for breast cancer is maintained in subsequent incidence screens, with better specificity and accuracy.

us, nl, il (code pays fourni par la source)

Clinical significance of lesion conspicuity on contrast-enhanced mammography

Tali Amir, CAROL H. LEE, Molly P. Hogan, Sarah Eskreis‐Winkler et autres

OBJECTIVE: To determine if lesion conspicuity on contrast-enhanced mammography (CEM) is independently associated with malignancy. MATERIALS AND METHODS: This retrospective, single-institution study identified consecutive abnormal screening and diagnostic CEMs between January 2019 and December 2021. The conspicuity of enhancing lesions on CEM …

us, il (code pays fourni par la source)

Interval Cancers after Negative Screening Contrast-enhanced Mammography

Tali Amir, Carol H Lee, Sarah Eskreis-Winkler, Molly P. Hogan et autres

In patients undergoing screening contrast-enhanced mammography, the interval cancer rate was 2.29 cancers per 1000 examinations, and invasive interval cancers were associated with moderate or marked background parenchymal enhancement.

us, il (code pays fourni par la source)

Longitudinal fluctuations in reported background parenchymal enhancement on contrast enhanced mammography

Noam Nissan, Jeffrey S. Reiner, Yuki Arita, Tali Amir et autres

us, il (code pays fourni par la source)

Data from A Co-clinical Trial of Exercise Therapy in Breast Cancer Prevention

Lee W. Jones, Jessica A. Lavery, Brandon L. Tsai, Chaya S. Moskowitz et autres

AbstractPurpose: We conducted a mouse–human co-clinical trial to evaluate the biological efficacy of exercise therapy in breast cancer prevention. Patients and Methods: In a phase I randomized trial, 75 nonexercising women at high risk of breast cancer were allocated to receive (1:1 …

The role of mammography in the detection and diagnosis of pregnancy-associated breast cancer

Noam Nissan, Jonathan Kuten, Kimberly Feigin, Victoria L. Mango et autres

us (code pays fourni par la source)

A Co-clinical Trial of Exercise Therapy in Breast Cancer Prevention

Lee W. Jones, Jessica A. Lavery, Brandon L. Tsai, Chaya S. Moskowitz et autres

PURPOSE: We conducted a mouse-human co-clinical trial to evaluate the biological efficacy of exercise therapy in breast cancer prevention. PATIENTS AND METHODS: In a phase I randomized trial, 75 nonexercising women at high risk of breast cancer were allocated to receive (1:1 …

us (code pays fourni par la source)

Comparison of Contrast-enhanced Mammography and Low-Energy Imaging with or without Supplemental Whole-Breast US in Breast Cancer Detection

João V. Horvat, Tali Amir, Gordon P. Watt, Christopher Comstock et autres

of 9 of 20 [45.0%]). Conclusion Breast cancer detection improved with CEM compared with LE images alone or LE images with whole-breast US. ClinicalTrials.gov Identifier: NCT02310698 © RSNA, 2025

us (code pays fourni par la source)

Quantitative Changes in Breast Density and Mammographic Features Induced by Pregnancy and Lactation: A Longitudinal Study

Noam Nissan, Jonathan Kuten, Kimberly Feigin, Jill S. Gluskin et autres

OBJECTIVE: Quantitative changes in mammographic properties during pregnancy and lactation remain underexplored. Therefore, the purpose of this study was to quantify mammographic changes in the breast from prepregnancy through lactation to postweaning at the individual level. METHODS: Mammograms of 39 women at …

us (code pays fourni par la source)

Breast Cancer Recurrence after Cryoablation in Patients Who Are Poor Surgical Candidates or Who Refuse Surgery

Jolie Jean, Maxine S. Jochelson, Tracy‐Ann Moo, Stephen B. Solomon et autres

us (code pays fourni par la source)

Hormonal Regulation of Background Parenchymal Enhancement at Contrast-enhanced Mammography

Noam Nissan, Varadan Sevilimedu, Jill S. Gluskin, Yuki Arita et autres

Background parenchymal enhancement observed at contrast-enhanced mammography decreased with menopause and use of tamoxifen and increased with lactation, hormone replacement therapy use, and tamoxifen cessation, suggesting these effects should be considered at imaging interpretation.

us (code pays fourni par la source)

Non-enhancing asymmetries on screening contrast-enhanced mammography: Is further diagnostic workup required?

Noam Nissan, Jeffrey S. Reiner, Victoria L. Mango, Hila Fruchtman-Brot et autres

us (code pays fourni par la source)